These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20694902)

  • 41. Is there a case for a distinction between ethics and policy?
    Hunter D
    Am J Bioeth; 2010 Jun; 10(6):24-5. PubMed ID: 20526965
    [No Abstract]   [Full Text] [Related]  

  • 42. Protecting human subjects in neurosurgical trials: the challenge of psychogenic dystonia.
    Bramstedt KA; Ford PJ
    Contemp Clin Trials; 2006 Apr; 27(2):161-4. PubMed ID: 16387556
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paediatric treatment trials for COVID-19 are an ethical imperative.
    Gwee A; Boast A; Osowicki J; Steer AC; Coghlan S
    Arch Dis Child; 2021 Feb; 106(2):e4. PubMed ID: 32518135
    [No Abstract]   [Full Text] [Related]  

  • 44. Surgical experimentation and clinical trials: differences and related ethical problems.
    Petrini C
    Ann Ist Super Sanita; 2013; 49(2):230-3. PubMed ID: 23771267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Controlling Ebola trials.
    Millum J
    Am J Bioeth; 2015; 15(4):36-7. PubMed ID: 25856597
    [No Abstract]   [Full Text] [Related]  

  • 46. The goals of research during an epidemic.
    Rid A
    Am J Bioeth; 2015; 15(4):47-50. PubMed ID: 25856602
    [No Abstract]   [Full Text] [Related]  

  • 47. Trials and errors: barriers to oversight of research conducted under the emergency research consent waiver.
    Kipnis K; King NM; Nelson RM
    IRB; 2006; 28(2):16-9. PubMed ID: 16770884
    [No Abstract]   [Full Text] [Related]  

  • 48. Thoughts on alternative designs for clinical trials for Ebola treatment research.
    Waldman R; Nieburg P
    Am J Bioeth; 2015; 15(4):38-40. PubMed ID: 25856598
    [No Abstract]   [Full Text] [Related]  

  • 49. Demarcating research and treatment: a systematic approach for the analysis of the ethics of clinical research.
    Freedman B; Fuks A; Weijer C
    Clin Res; 1992 Dec; 40(4):653-60. PubMed ID: 1486732
    [No Abstract]   [Full Text] [Related]  

  • 50. The view from the inside: more confusion (and coziness) than consent.
    Green J
    Am J Bioeth; 2010 Sep; 10(9):60-1. PubMed ID: 20818566
    [No Abstract]   [Full Text] [Related]  

  • 51. Is a placebo-controlled surgical trial an oxymoron?
    Boyle K; Batzer FR
    J Minim Invasive Gynecol; 2007; 14(3):278-83. PubMed ID: 17478356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expand the toolkit!
    Louis TA
    Am J Bioeth; 2015; 15(4):40-2. PubMed ID: 25856599
    [No Abstract]   [Full Text] [Related]  

  • 53. The past, present, and future of comparative effectiveness research in the US Department of Veterans Affairs.
    Kupersmith J; Ommaya AK
    Am J Med; 2010 Dec; 123(12 Suppl 1):e3-7. PubMed ID: 21184864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical research process: building a system in harmony with its users.
    Koski G
    Cancer Treat Res; 2007; 132():275-90. PubMed ID: 17305028
    [No Abstract]   [Full Text] [Related]  

  • 55. Against the principle that the individual shall have priority over science.
    Helgesson G; Eriksson S
    J Med Ethics; 2008 Jan; 34(1):54-6. PubMed ID: 18156523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Placebo use in clinical practice: report of the American Medical Association Council on Ethical and Judicial Affairs.
    Bostick NA; Sade R; Levine MA; Stewart DM;
    J Clin Ethics; 2008; 19(1):58-61. PubMed ID: 18552054
    [No Abstract]   [Full Text] [Related]  

  • 57. Not all RCTs are created equal: lessons from early AIDS trials.
    Dawson L
    Am J Bioeth; 2015; 15(4):45-7. PubMed ID: 25856601
    [No Abstract]   [Full Text] [Related]  

  • 58. New challenges in translational medicine: transforming the advancement of science into cures. Preface.
    Garaci E; Popoli P
    Ann Ist Super Sanita; 2011; 47(1):5-7. PubMed ID: 21430330
    [No Abstract]   [Full Text] [Related]  

  • 59. When are research risks reasonable in relation to anticipated benefits?
    Weijer C; Miller PB
    Nat Med; 2004 Jun; 10(6):570-3. PubMed ID: 15170195
    [No Abstract]   [Full Text] [Related]  

  • 60. Right job, wrong tool: a commentary on designing clinical trials for Ebola virus disease.
    Nelson RM; Roth-Cline M; Prohaska K; Cox E; Borio L; Temple R
    Am J Bioeth; 2015; 15(4):33-6. PubMed ID: 25856596
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.